Study probes hormone-linked gene expression in female dogs’ MCTs

A new study in Animals examined gene expression tied to hormone signaling and tumor growth in skin samples from intact and spayed female dogs, both with and without cutaneous mast cell tumors. The researchers evaluated markers including VEGF, IGF-1, PCNA, Ki-67, c-KIT, luteinizing hormone receptor, follicle-stimulating hormone receptor, and estrogen receptor alpha to explore whether reproductive status might shape the molecular environment around these tumors. The question matters because canine mast cell tumors are the most common malignant skin tumors in dogs, and prior work has suggested that gonadectomy may alter gonadotropin signaling in ways that could affect tumor biology. (mdpi.com)

Why it matters: For veterinary professionals, this study adds to a growing body of work looking beyond histologic grade alone and into whether endocrine status may influence mast cell tumor behavior. That doesn’t change clinical recommendations on spay timing or mast cell tumor management today, because broader reviews still describe the evidence on sex and neuter status as mixed or inconsistent. But it does reinforce that hormone receptor pathways, proliferation markers such as Ki-67, and angiogenesis-related signals like VEGF remain active areas of translational oncology research that could eventually inform risk stratification or targeted approaches. (mdpi.com)

What to watch: The next step is whether these gene-expression findings are validated in larger cohorts and linked to outcomes such as grade, recurrence, metastasis, or treatment response. (mdpi.com)